http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104541169-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104541169-B |
titleOfInvention | The tuberculosis infection state of individual |
abstract | In a first aspect, the present invention relates to diagnosis or determine suffer from or the doubtful individual tuberculosis infection state with tuberculosis infection method.On the other hand, the with different levels method of therapeutic scheme to tuberculosis infection individual, and prediction are additionally provided with the individual clinical effectiveness of tuberculosis infection or the method for determining the course for the treatment of.In addition, the present invention provides the method that the tuberculosis infection in monitoring individual changes from hiding to active state (or its inverse process).In addition, the present invention relates to the kit for diagnosing or detecting tuberculosis infection state, and application of mycobacterium tuberculosis (Mycobacterium tuberculosis) alanine dehydrogenase in the tuberculosis latence and active disease state that specificity distinguishes individual. |
priorityDate | 2012-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.